Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer
Ohkawa, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 198-202
2006
ISSN/ISBN: 0047-1852 PMID: 16457249 Document Number: 603621
Document emailed within 1 workday
Related Documents
Hayashi, K.; Uchida, K.; Hatori, T.; Takasaki, K. 2006: TS-1: S-1 based chemotherapy for far-advanced or relapsed pancreatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 194-197Inal, A.; Kos, F.T.; Algin, E.; Yildiz, R.; Berk, V.; Tugba Unek, I.; Colak, D.; Colak, D.; Kucukoner, M.; Tamer Elkiran, E.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Ali Kaplan, M.; Gok Durnali, A.; Harputoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Gumus, M.; Ozkan, M.; Benekli, M.; Isikdogan, A. 2012: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(1): 102-105
Gansauge, F.; Ramadani, M.; Schwarz, M.; Beger, H.G.; Lotspeich, E.; Poch, B. 2007: The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer Hepato-Gastroenterology 54(75): 917-920
Fujimoto, C.; Maruyama, Y.; Niina, Y.; Fujimori, N.; Sumii, T.; Funakoshi, A. 2008: A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(6): 1013-1016
Sunagozaka, H.; Yamashita, T.; Kagaya, T.; Kato, Y.; Kaneko, S. 2006: A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 829-832
Sumiyoshi, H.; Matsushita, A.; Nakamura, Y.; Yamahatsu, K.; Katsuno, A.; Uchida, E. 2014: Radical resection of a locally advanced pancreatic tail adenosquamous carcinoma treated with S-1 and gemcitabine as neoadjuvant chemotherapy - a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(5): 669-672
Kurtz, J.E.; Kohser, F.; Négrier, S.; Trillet-Lenoir, V.; Walter, S.; Limacher, J.M.; Untereiner, M.; Kayitalire, L.; Jaeck, D.; Dufour, P. 2000: Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study Hepato-Gastroenterology 47(35): 1450-1453
Baba, H.; Suzuki, Y.; Ema, T.; Kawakami, M.; Nakanishi, C.; Hashimoto, T.; Arai, T.; Matsumoto, G.; Tsuruta, K.; Okamoto, A.; Karasawa, K. 2005: Gemcitabine concurrent with radiation for locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1730-1732
Masaki, T.; Ohkawa, S.; Hirokawa, S.; Miyakawa, K.; Tamai, S.; Tarao, K. 2003: A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(9): 1333-1336
Yajima, T.; Furukawa, Y.; Ishii, Y.; Hattori, Y.; Matsumoto, N.; Yamamoto, M.; Yamaoka, Y.; Fujihara, M.; Fujita, M.; Kuniki, H. 2004: Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 953-957
Shiozawa, S.; Tsuchiya, A.; Kumazawa, K.; Ogawa, K. 2003: Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(4): 483-487
Cucević, B.; Samarzija, M.; Baricević, D.; Jakopović, M.; Redzepi, G.; Samija, M. 2005: Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer Collegium Antropologicum 29(2): 583-588
Wolf, H.; Jassem, E.; Cynowska, B.ła.; Damps, I.; Mierzejewska, E.; Słomiński, J.M. 2002: Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin Pneumonologia i Alergologia Polska 70(1-2): 44-51
Takahata, T.; Sato, A.; Yu, C.; Saito, K. 2018: Retrospective Analysis of Weekly Paclitaxel Chemotherapy for Gemcitabine- and S-1-Resistant Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 817-821
Watanabe, F.; Honda, G.; Kurata, M.; Tsuruta, K.; Tokashiki, T.; Funada, N. 2009: A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2430-2432
Tanaka, S.; Fujii, M.; Goubaru, M.; Ohta, T.; Ogata, M.; Makino, Y. 2005: Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(10): 1485-1487
Nagamatsu, Y.; Nakarai, I.; Matsuo, T.; Kawahara, M.; Shinoda, A. 1986: A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3527-3531
Nakamoto, S.; Nishiyama, R.; Kaneda, T.; Yokota, M.; Kawamata, H.; Tajima, H.; Kaizu, T.; Kumamoto, Y.; Yamauchi, H.; Okuwaki, K.; Iwai, T.; Imaizumi, H.; Suzuki, E.; Hara, A.; Ichinoe, M.; Kida, M.; Watanabe, M. 2017: Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(2): 173-176
Bunn, P.A. 1999: Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer Seminars in Oncology 26(1 Suppl 4: 25-30
Hoshino, H.; Takeda, Y.; Nagano, H.; Nakamori, S.; Kobayashi, S.; Eguchi, H.; Marubashi, S.; Tanemura, M.; Kitagawa, T.; Umeshita, K.; Monden, M.; Doki, Y.; Mori, M. 2009: A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2419-2421